Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Dactinomycin × Sarcoma × Clear all

Phase

Phase 3 12 Phase 2 10 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Rhabdomyosarcoma 1

Interventions

Temozolomide 29 Radiotherapy 27 Irinotecan 14 Gemcitabine 14 Cyclophosphamide 14 Doxorubicin 13 pembrolizumab 12 Imatinib Mesylate 9 Docetaxel 9 Radiation 8 Nivolumab 8 Ifosfamide 8 Bevacizumab 8 Sirolimus 7 Filgrastim 7 Everolimus 7 Carboplatin 7 Vincristine 6 pazopanib 5 Specimen Handling 5 Peripheral Blood Stem Cell Transplantation 5 PM 01183 5 Etoposide 5 Biopsy 5 temsirolimus 4 lenvatinib 4 avelumab 4 atezolizumab 4 X-Rays 4 Vorinostat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04625907 2024-05-23

FaR-RMS

University of Birmingham

Phase 1/2 Recruiting

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡